WHO WE ARE
We are a biotechnology company focused on the research and development of transformational therapies to address significant health challenges globally.
We are dedicated to developing novel vaccines that induce durable and long-term immunity. We believe that our pipeline and vaccine platform are synergistic for developing next generation preventive vaccines to improve both health outcomes and quality of life globally.
Our versatile vaccine platform has unique molecular properties that enables delivery of various antigens, which can be utilized to develop singular or multi-targeted vaccines.
Blue Water Biotech, Inc. purchased ENTADFI®, a treatment for benign prostatic hyperplasia.